Stay updated with breaking news from Liver Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Durvalumab plus a single priming dose of tremelimumab led to continued clinically meaningful overall survival benefit at 4 years compared with sorafenib in patients with previously untreated, unresectable hepatocellular carcinoma not eligible for localized therapy.
The figures are alarming: An estimated 18 million Filipinos are either suffering from liver disease or are at risk of getting it.
A HEARTBROKEN mum who took her own life as the anniversary of her son's death approached was the subject of 'several missed opportunities' by…
Hepatocellular carcinoma and lung cancer patients are set to benefit from the recent approval of Imfinzi plus Imjudo combinations in the EU.
A Kilkeny native is part of an aspiring trio who are getting set to run all the way from Monaghan to Mayo (210km) as part of a special charity fundraiser. Bob G...